Developer docs
API playgroundTry for free, no card

Search company profiles

Solta Medical

Full company profile

uuid0009ump

Namestring
Solta Medical
Legal namestring
Solta Medical Inc.
Websiteurl
solta.com
Company typeenum
Private
Founded yearint
1995
Descriptiontext

Solta Medical, a wholly-owned subsidiary of Bausch Health Companies Inc. (NYSE: BHC), designs, develops, and markets energy-based medical device systems for aesthetic applications. Founded in 1995 and headquartered in Bothell, Washington with 251-500 employees, the company sells a portfolio of FDA-cleared, Health Canada-approved, and NMPA-approved devices: Thermage FLX (monopolar radiofrequency skin tightening, the only non-invasive technology indicated for upper and lower eyelids), Clear + Brilliant Touch (dual-wavelength non-ablative fractional laser), Fraxel FTX (1550nm/1927nm fractional laser), VASERlipo (ultrasonic body contouring), and the UltraCel Q+ multi-technology platform. The Thermage brand has surpassed 5 million cumulative treatments globally and received AAA Well-Known Trademark Certification in China in 2026.

Solta generates revenue primarily through direct capital equipment sales to physicians, dermatologists, cosmetic surgeons, medical spas, and aesthetic clinics, with international markets historically served through channel partners. In December 2025, the company acquired its longtime Chinese distributor (Wuhan Shibo Zhenmei Technology) to directly control its China distribution network — a market where Thermage contributed 33% of brand revenue in 2022. The go-to-market combines enterprise field sales, a consumer-facing "Find a Provider" referral tool, dedicated brand-specific product websites, and national PR-driven marketing such as the October 2025 feature on Lifetime's The Balancing Act. Geographic coverage spans the United States, Canada (entry February 2026), and China, with a global footprint claim across additional markets.

Short descriptiontext

Solta Medical, a Bausch Health subsidiary, designs and markets energy-based aesthetic medical devices — including Thermage FLX, Clear + Brilliant, Fraxel, and VASERlipo — sold directly to physicians, dermatologists, and medspas across the US, Canada, and China.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersHayward, United States
HQ citystring
Hayward
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
aesthetic medical devices, radiofrequency skin tightening, fractional laser systems, ultrasonic body contouring, energy-based aesthetics
Industry2 codes
1Laser & Energy-Based Dermatology
CodeHLAKACAFPrimaryYes
2Skincare Devices & Beauty Tech (LED, Microcurrent, Cleansing Devices)
CodeCRABAAAJPrimaryNo
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code1 code
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Aesthetic Medical Devices
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model2 records
1Medical Device Sales
TypeHardware Sales
Description

Solta Medical generates revenue through the sale of aesthetic medical devices to physicians, dermatologists, and medical practices. The company sells equipment outright to practitioners who then use them to perform treatments on patients.

solta.com
2Thermage Brand Revenue (China)
TypeHardware Sales
Description

China operations contributed 33% of Thermage's revenue in 2022, demonstrating significant international revenue streams from aesthetic device treatments and related operations in the Asia-Pacific region.

stocktitan.net
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1Thermage
Description

Radiofrequency skin tightening system for non-invasive treatment of wrinkles and skin laxity

solta.com
+3 more records
Core offering1 text field

Solta Medical designs, develops, and markets energy-based medical device systems for aesthetic applications. Its product portfolio includes the Thermage FLX monopolar radiofrequency skin tightening system, Clear + Brilliant Touch dual-wavelength fractional laser, Fraxel FTX 1550nm/1927nm fractional laser systems, VASERlipo ultrasonic body contouring system, and UltraCel Q+ multi-technology platform. These devices are sold to physicians, dermatologists, and medical practices to deliver non-invasive skin rejuvenation, skin tightening, wrinkle reduction, and body contouring treatments.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Over 5 million Thermage treatments performed worldwide
+1 more record
Product overview1 text field

Solta Medical, a division of Bausch Health, offers a portfolio of energy-based aesthetic medical devices including Thermage FLX (monopolar radiofrequency skin tightening), Clear + Brilliant Touch (dual-wavelength fractional laser), Fraxel FTX (1550nm/1927nm laser systems), and VASERlipo (ultrasonic liposuction system). The company also offers UltraCel Q+ platform. These devices target non-invasive skin rejuvenation, body contouring, and surgical aesthetic procedures across dermatology and plastic surgery applications.

Product and service5 records
1Thermage FLX
2Clear + Brilliant Touch
CategoryFractional laser system
Description

Dual-wavelength non-ablative fractional laser system for non-invasive skin rejuvenation that improves skin tone, texture, fine lines, pore size, and overall skin appearance. Suitable for all skin types. Sold to physicians and aesthetic practices.

3Fraxel FTX
CategoryFractional laser system
Description

Fractional laser system offering 1550nm and 1927nm wavelengths for skin resurfacing, treatment of dyschromia, actinic keratosis, melasma, wrinkles around eyes, acne scars, surgical scars, and pigmented lesions. Sold to physicians and dermatologists.

4VASERlipo System
CategoryUltrasonic body contouring system
Description

Ultrasonic liposuction system for aesthetic body contouring and soft tissue removal across multiple surgical specialties including plastic and reconstructive surgery, dermatologic procedures, and general surgical applications. Sold to plastic surgeons and surgical practices.

5UltraCel Q+
CategoryMulti-technology energy-based aesthetic platform
Description

Multi-technology aesthetic platform combining radiofrequency, microneedling, and other energy-based treatments for skin tightening and contouring. Sold to physicians and aesthetic practices.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Wuhan Shibo Zhenmei Technology Co., Ltd.
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-12-01
Description

Solta Medical acquired its longtime Chinese distribution partner Wuhan Shibo Zhenmei Technology (also referred to as Shibo Group) effective December 1, 2025, becoming its sole owner and fully controlling its China operations. The acquisition enables Solta Medical to directly manage its distribution network and address increasing demand for aesthetic treatments in China, where the Thermage brand has been present for over a decade and contributed 33% of Thermage's revenue in 2022.

biospace.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

BTL Aesthetics markets non-invasive body contouring and skin treatment devices (EMSCULPT, EMSELLA, EMFACE) used by medspas and physicians, directly overlapping with Solta's VASERlipo and Thermage categories in the same customer base.

TypeDirect peer
Description

Lumenis is a long-standing energy-based device maker (laser, IPL, RF) serving the same dermatology, plastic surgery, and medspa channels. Acquired by Boston Scientific, it competes with Solta's laser and RF platforms including Fraxel and Clear + Brilliant.

TypeDirect peer
Description

InMode is a fast-growing energy-based aesthetic device company whose RF, laser, and body contouring platforms (Morpheus8, Evolve, BodyTite) compete head-to-head with Solta's Thermage and body contouring offerings in dermatology and plastic surgery practices.

TypeDirect peer
Description

Allergan Aesthetics, an AbbVie company, is explicitly co-identified with Solta as a top-2 player in anti-aging/aesthetic devices. Its portfolio (CoolSculpting, SkinMedica, Botox) overlaps Solta's energy-based device franchise across the same physician and medspa customer base.

TypeDirect peer
Description

Cutera develops and markets laser and energy-based aesthetic systems (e.g., AviClear, ExcelV) for dermatologists and aesthetic practices, directly competing with Solta's laser and skin rejuvenation portfolio.

TypeDirect peer
Description

Candela manufactures energy-based aesthetic and medical laser systems used by dermatologists and plastic surgeons. Its portfolio competes with Solta's Fraxel fractional laser and other resurfacing devices in similar clinical and medspa settings.

TypeEmerging player
Description

Venus Concept markets energy-based aesthetic devices (RF, IPL, body contouring) primarily to medspas and aesthetic practices, partially overlapping Solta's portfolio with focus on more entry-level and consumable-driven economics.

TypeDirect peer
Description

Alma Lasers produces RF, laser, ultrasound, and body contouring aesthetic devices for physicians and medspas, directly competing with Solta's Thermage, Clear + Brilliant, and VASERlipo platforms across overlapping indications.

TypeDirect peer
Description

Cynosure Lutronic manufactures energy-based aesthetic devices including fractional lasers, RF platforms, and body contouring systems sold to dermatologists and medspas, directly overlapping Solta's Thermage, Fraxel, and VASERlipo categories.

TypeEmerging player
Description

Sciton produces laser and light-based aesthetic and medical platforms (HALO, BBL, MOXI) sold to dermatologists and plastic surgeons, with meaningful overlap to Solta's Fraxel and Clear + Brilliant resurfacing technologies.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors5 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A4 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Solta Medical

Aesthetic Medical Devicessolta.com

Solta Medical, a Bausch Health subsidiary, designs and markets energy-based aesthetic medical devices — including Thermage FLX, Clear + Brilliant, Fraxel, and VASERlipo — sold directly to physicians, dermatologists, and medspas across the US, Canada, and China.

What Solta Medical does

Solta Medical, a wholly-owned subsidiary of Bausch Health Companies Inc. (NYSE: BHC), designs, develops, and markets energy-based medical device systems for aesthetic applications. Founded in 1995 and headquartered in Bothell, Washington with 251-500 employees, the company sells a portfolio of FDA-cleared, Health Canada-approved, and NMPA-approved devices: Thermage FLX (monopolar radiofrequency skin tightening, the only non-invasive technology indicated for upper and lower eyelids), Clear + Brilliant Touch (dual-wavelength non-ablative fractional laser), Fraxel FTX (1550nm/1927nm fractional laser), VASERlipo (ultrasonic body contouring), and the UltraCel Q+ multi-technology platform. The Thermage brand has surpassed 5 million cumulative treatments globally and received AAA Well-Known Trademark Certification in China in 2026.

Solta generates revenue primarily through direct capital equipment sales to physicians, dermatologists, cosmetic surgeons, medical spas, and aesthetic clinics, with international markets historically served through channel partners. In December 2025, the company acquired its longtime Chinese distributor (Wuhan Shibo Zhenmei Technology) to directly control its China distribution network — a market where Thermage contributed 33% of brand revenue in 2022. The go-to-market combines enterprise field sales, a consumer-facing "Find a Provider" referral tool, dedicated brand-specific product websites, and national PR-driven marketing such as the October 2025 feature on Lifetime's The Balancing Act. Geographic coverage spans the United States, Canada (entry February 2026), and China, with a global footprint claim across additional markets.

Solta Medical firmographics

Firmographics
Name
Solta Medical
Legal name
Solta Medical Inc.
Website
https://solta.com
Company type
Private
Founded year
1995
Operating status
Operating
Headcount range
251–500 employees
Short description
Solta Medical, a Bausch Health subsidiary, designs and markets energy-based aesthetic medical devices — including Thermage FLX, Clear + Brilliant, Fraxel, and VASERlipo — sold directly to physicians, dermatologists, and medspas across the US, Canada, and China.
Ownership category
akta.pro rank

Solta Medical industry classification

Industry
Product category
Aesthetic Medical Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro primary industry
Laser & Energy-Based Dermatology (HLAKACAF)
akta.pro secondary industry
Skincare Devices & Beauty Tech (LED, Microcurrent, Cleansing Devices) (CRABAAAJ)

Keywords

  • Aesthetic medical devices
  • Radiofrequency skin tightening
  • Fractional laser systems
  • Ultrasonic body contouring
  • Energy-based aesthetics

Where Solta Medical is headquartered

Location

Headquarters

HQ city
Hayward
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Solta Medical business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Medical Device Sales: Solta Medical generates revenue through the sale of aesthetic medical devices to physicians, dermatologists, and medical practices. The company sells equipment outright to practitioners who then use them to perform treatments on patients.
  2. Thermage Brand Revenue (China): China operations contributed 33% of Thermage's revenue in 2022, demonstrating significant international revenue streams from aesthetic device treatments and related operations in the Asia-Pacific region.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Solta Medical product offering

Product offering

Core offering

Solta Medical designs, develops, and markets energy-based medical device systems for aesthetic applications. Its product portfolio includes the Thermage FLX monopolar radiofrequency skin tightening system, Clear + Brilliant Touch dual-wavelength fractional laser, Fraxel FTX 1550nm/1927nm fractional laser systems, VASERlipo ultrasonic body contouring system, and UltraCel Q+ multi-technology platform. These devices are sold to physicians, dermatologists, and medical practices to deliver non-invasive skin rejuvenation, skin tightening, wrinkle reduction, and body contouring treatments.

Product overview

Solta Medical, a division of Bausch Health, offers a portfolio of energy-based aesthetic medical devices including Thermage FLX (monopolar radiofrequency skin tightening), Clear + Brilliant Touch (dual-wavelength fractional laser), Fraxel FTX (1550nm/1927nm laser systems), and VASERlipo (ultrasonic liposuction system). The company also offers UltraCel Q+ platform. These devices target non-invasive skin rejuvenation, body contouring, and surgical aesthetic procedures across dermatology and plastic surgery applications.

Differentiator

Problem solved

Functional benefit

Brands

  • Thermage: Radiofrequency skin tightening system for non-invasive treatment of wrinkles and skin laxity
  • Clear + Brilliant
  • Fraxel
  • VASERlipo

Products and services

  • Thermage FLX
  • Clear + Brilliant Touch Dual-wavelength non-ablative fractional laser system for non-invasive skin rejuvenation that improves skin tone, texture, fine lines, pore size, and overall skin appearance. Suitable for all skin types. Sold to physicians and aesthetic practices.
  • Fraxel FTX Fractional laser system offering 1550nm and 1927nm wavelengths for skin resurfacing, treatment of dyschromia, actinic keratosis, melasma, wrinkles around eyes, acne scars, surgical scars, and pigmented lesions. Sold to physicians and dermatologists.
  • VASERlipo System Ultrasonic liposuction system for aesthetic body contouring and soft tissue removal across multiple surgical specialties including plastic and reconstructive surgery, dermatologic procedures, and general surgical applications. Sold to plastic surgeons and surgical practices.
  • UltraCel Q+ Multi-technology aesthetic platform combining radiofrequency, microneedling, and other energy-based treatments for skin tightening and contouring. Sold to physicians and aesthetic practices.

Quantifiable outcome

  • Over 5 million Thermage treatments performed worldwide
  • +1 more outcomes

Companies that use Solta Medical

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Solta Medical technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Solta Medical partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Wuhan Shibo Zhenmei Technology Co., Ltd.coreChannel Partner/ Reseller/ Distributor · 1 December 2025Solta Medical acquired its longtime Chinese distribution partner Wuhan Shibo Zhenmei Technology (also referred to as Shibo Group) effective December 1, 2025, becoming its sole owner and fully controlling its China operations. The acquisition enables Solta Medical to directly manage its distribution network and address increasing demand for aesthetic treatments in China, where the Thermage brand has been present for over a decade and contributed 33% of Thermage's revenue in 2022.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

Solta Medical competitors and assessment

Company assessment

Direct peers

  • BTL Aesthetics: BTL Aesthetics markets non-invasive body contouring and skin treatment devices (EMSCULPT, EMSELLA, EMFACE) used by medspas and physicians, directly overlapping with Solta's VASERlipo and Thermage categories in the same customer base.
  • Lumenis (Boston Scientific): Lumenis is a long-standing energy-based device maker (laser, IPL, RF) serving the same dermatology, plastic surgery, and medspa channels. Acquired by Boston Scientific, it competes with Solta's laser and RF platforms including Fraxel and Clear + Brilliant.
  • InMode Ltd. InMode is a fast-growing energy-based aesthetic device company whose RF, laser, and body contouring platforms (Morpheus8, Evolve, BodyTite) compete head-to-head with Solta's Thermage and body contouring offerings in dermatology and plastic surgery practices.
  • Allergan Aesthetics (AbbVie): Allergan Aesthetics, an AbbVie company, is explicitly co-identified with Solta as a top-2 player in anti-aging/aesthetic devices. Its portfolio (CoolSculpting, SkinMedica, Botox) overlaps Solta's energy-based device franchise across the same physician and medspa customer base.
  • Cutera Inc. Cutera develops and markets laser and energy-based aesthetic systems (e.g., AviClear, ExcelV) for dermatologists and aesthetic practices, directly competing with Solta's laser and skin rejuvenation portfolio.
  • Candela Corporation: Candela manufactures energy-based aesthetic and medical laser systems used by dermatologists and plastic surgeons. Its portfolio competes with Solta's Fraxel fractional laser and other resurfacing devices in similar clinical and medspa settings.
  • Alma Lasers: Alma Lasers produces RF, laser, ultrasound, and body contouring aesthetic devices for physicians and medspas, directly competing with Solta's Thermage, Clear + Brilliant, and VASERlipo platforms across overlapping indications.
  • Cynosure Lutronic: Cynosure Lutronic manufactures energy-based aesthetic devices including fractional lasers, RF platforms, and body contouring systems sold to dermatologists and medspas, directly overlapping Solta's Thermage, Fraxel, and VASERlipo categories.

Emerging players

  • Venus Concept Inc. Venus Concept markets energy-based aesthetic devices (RF, IPL, body contouring) primarily to medspas and aesthetic practices, partially overlapping Solta's portfolio with focus on more entry-level and consumable-driven economics.
  • Sciton Inc. Sciton produces laser and light-based aesthetic and medical platforms (HALO, BBL, MOXI) sold to dermatologists and plastic surgeons, with meaningful overlap to Solta's Fraxel and Clear + Brilliant resurfacing technologies.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Solta Medical social profiles

Digital presence

Solta Medical compliance and trust

Trust signal

Compliance1 record

Solta Medical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Solta Medical leadership team

Management profile

Number of profiles

Profiles5 records

Solta Medical subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Solta Medical funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Solta Medical M&A and investment

M&A and investment

M&A4 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Solta Medical

What does Solta Medical do?

Solta Medical designs, develops, and markets energy-based medical device systems for aesthetic applications. Its product portfolio includes the Thermage FLX monopolar radiofrequency skin tightening system, Clear + Brilliant Touch dual-wavelength fractional laser, Fraxel FTX 1550nm/1927nm fractional laser systems, VASERlipo ultrasonic body contouring system, and UltraCel Q+ multi-technology platform. These devices are sold to physicians, dermatologists, and medical practices to deliver non-invasive skin rejuvenation, skin tightening, wrinkle reduction, and body contouring treatments.

Is Solta Medical a public or private company?

Solta Medical is a private company. It is classified as corporate owned and is currently operating.

When was Solta Medical founded?

Solta Medical was founded in 1995. It employs 251 to 500 people.

Where is Solta Medical based?

Solta Medical is headquartered in Hayward, United States, in the North America region.

How does Solta Medical make money?

Two revenue lines are on record. Medical Device Sales are the primary driver. The others are thermage Brand Revenue (China).

Who are Solta Medical's main competitors?

Direct peers on record are BTL Aesthetics, Lumenis (Boston Scientific), InMode Ltd., Allergan Aesthetics (AbbVie), Cutera Inc., Candela Corporation, Alma Lasers and Cynosure Lutronic. Emerging players are Venus Concept Inc. and Sciton Inc..

Does Solta Medical have an API?

No public API is recorded for Solta Medical.

What industry is Solta Medical in?

Solta Medical's product category is Aesthetic Medical Devices. Its primary akta.pro industry code is HLAKACAF, Laser & Energy-Based Dermatology, with a secondary code of CRABAAAJ, Skincare Devices & Beauty Tech (LED, Microcurrent, Cleansing Devices). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BusinesskoreaSolta Medical Korea holds Thermage FLX Symposium... sharing the latest clinical trendsSolta Medical Korea held the SOMA Thermage FLX Symposium in Seoul on August 29, featuring presentations on the Thermage Delphi Consensus and Eye Thermage White Paper. A panel discussed consumer perception trends, and CEO Han Sang-jin said the company will continue sharing clinical insights through academic activities.Investing.comBausch Health launches Fraxel FTX laser system in Australia By Investing.comBausch Health announced the availability of its Fraxel FTX laser system in Australia through Solta Medical. The system uses two wavelengths for skin resurfacing, targeting fine lines, wrinkles, and pigmented lesions, and is available by prescription only.YahooBausch Health Announces Availability of Solta Medical's Fraxel FTX® in AustraliaBausch Health's Solta Medical announced Fraxel FTX availability in Australia from September 1, 2026. The dual-wavelength laser system targets epidermal and dermal layers, with ergonomic handpiece and integrated cooling. The company aims to support treatment precision and patient comfort.Stock TitanBausch Health Makes Fraxel FTX Available in AustraliaBausch Health announced that Solta Medical's Fraxel FTX laser system will be available to Australian health care practitioners starting September 1, 2026. The system uses dual wavelengths (1927 nm and 1550 nm) for skin resurfacing, addressing fine lines, scars, and dyschromia. It includes an ergonomic handpiece and integrated cooling for patient comfort.NewswireBausch Health Announces Availability of Solta Medical's Fraxel FTX® in AustraliaBausch Health's Solta Medical announced Fraxel FTX availability in Australia from September 1, 2026. The dual-wavelength system targets epidermal and dermal layers, addressing fine lines, scars, and dyschromia. The company will provide clinical education and training to Australian practitioners.MorningstarBausch Health Announces Availability of Solta Medical's Fraxel FTX® in AustraliaBausch Health announced that Solta Medical's Fraxel FTX laser system will be available to Australian healthcare practitioners starting September 1, 2026. The system uses dual wavelengths (1927 nm and 1550 nm) for skin resurfacing, addressing fine lines, scars, and dyschromia. It includes an ergonomic handpiece and integrated cooling for patient comfort.PR Newswire APACBausch Health Announces Availability of Solta Medical's Fraxel FTX® in AustraliaBausch Health's Solta Medical announced Fraxel FTX availability in Australia from 1 September 2026. The dual-wavelength laser addresses fine lines, scars, and dyschromia, with ergonomic and cooling features. The product is not available for general public purchase.YahooBHC Q2 Earnings Beat Estimates on Salix and Solta Growth, '26 View RaisedBausch Health Companies Inc. reported second-quarter 2026 adjusted earnings of $1.26 per share, up 40% year over year, beating the Zacks Consensus Estimate of 96 cents, while revenues increased 13% to $2.85 billion, surpassing the consensus estimate of $2.65 billion. Growth was driven primarily by Salix at $758 million (up 21%), Solta Medical at $176 million (up 38%), and Bausch + Lomb, with Xifaxan emerging as the key revenue engine at $664 million (up 26% due to higher pricing and volume growth). The company completed its acquisition of Shibo's full-service aesthetics distribution business in China, strengthening Solta Medical's geographic footprint in the Asia-Pacific region.스타트업엔(StartupN)Solta Medical Korea and TNH join hands... Full-scale introduction of Thermage FLX digital consultation solutionSolta Medical Korea and TNH launched the Thermage FLX digital consultation solution on the 18th, using TNH's VegasCRM platform. The tablet-based tool lets staff display and save treatment plans, with security measures to avoid storing patient data. Both companies plan to expand digital support activities.PR NewswireBausch Health's Aesthetic Business, Solta Medical, Earns Prestigious Trademark Certification of Thermage® in ChinaBausch Health's Solta Medical announced that its Thermage® brand received the AAA Well-Known Trademark Certification from the China Trademark Association, placing it among only 217 brands in mainland China to achieve this distinction. The certification recognizes Thermage's brand reputation, consumer confidence, and market influence following over a decade of presence in China and more than 5 million treatments performed worldwide. Bausch Health CEO Thomas J. Appio and Solta Medical SVP Jiny Kim cited the recognition as validation of the brand's reliability and commitment to quality and safety standards.